pharmaceutical industry. Production line machine conveyor with glass bottles ampoules at factory
MimiVax awarded Orphan Drug Designation by US FDA for SurVaxM to treat glioblastoma patients
Novel immunotherapy, SurVaxM, being developed as treatment for glioblastoma BUFFALO, N.Y. — The U.S. Food and Drug Administration has awarded orphan drug status to a promising immunotherapy vaccine developed at…
Continue Reading MimiVax awarded Orphan Drug Designation by US FDA for SurVaxM to treat glioblastoma patients